Drugs / CCS/C
last change Feb 2010 re-read 2 minutes ago

CCS/C

Developed for
influenza
Investigated by
NasVax Ltd

Trials 1 · a red edge is where a trial was stopped

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00915187 Oct → Dec 2009 influenza NasVax Ltd Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CCS/C CCS/C (Adjuvant Formulation)” NCT00915187
Route Intramuscular “given once intramuscularly (IM)” NCT00915187